Get started

Cue Biopharma, Inc.

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

CUE chart

Key stats

Market capitalization
108.296MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.20USD
Net income
−53.01MUSD
Revenue
1.245MUSD
Shares float
42.022M
Beta
3.53

About Cue Biopharma, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Daniel R. Passeri
Website
cuebiopharma.com
Headquarters
Boston
Employees (FY)
51
Founded
2014
ISIN
US22978P1066
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Ideas

Cue Biopharma, IncOn the above two Weekly chart price action has corrected almost 90% since June 2020. A number of reasons now exist to be bullish , including: 1) A strong buy signal prints (not shown). 2) Regular bullish divergence . Multiple oscillators printing divergence. 3) Price action confirms support on past
Long
by without_worries
5
Cue Biopharma, bullishCue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer, infectious diseases and autoimmune diseases
Long
by zrrsys
Tutorial: Super simple buying and selling stocks in Trading ViewJust thought I would create a quick video to show how easy it is to buy and sell stocks within Trading View. I use Trade Station as the broker - Note: You need to use the US Trade Station. I dont think the International Trade Station works with Trading View. If you would like to sign up to Trading
Education
by zAngus
39
$CUE:NASDA - CUE BIOPHARMA - 100% run over the last month.Cue has been having a great run of late - up 100% over the last month and up a bit over 200% over the last 6 months. Its been running pretty hard for a while so might be overextended, but I like what they do and could be worth a watch. Be careful of pullbacks. Cue Biopharma, a clinical-stage bioph
Long
by zAngus
1
Cue Biopharma, Inc. On breakout alert $cueOn breakout alert today. Looking for entry on backtest and confirmation of support Cue Biopharma, Inc. is a biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of
by Bullishcharts

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Earnings
‪0‬

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.4Very Good
Learn more

See all brokers